Several retrospective studies have suggested p53 gene mutation as an adverse prognostic indicator in breast cancer patients, based on a selective growth advantage of p53 mutant cancer cells and their presumed resistance to current adjuvant therapy regimens. A cohort of 90 Caucasian midwestern breast
Is volume the most important predictor of outcome in cancer management?
β Scribed by Frederick L. Greene
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 65 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Gain of chromosome 1q is a hallmark of breast cancer, and likely reflects oncogene amplification. We previously identified mitotic kinesin __KIF14__ (kinesin family member 14) as an overexpressed candidate oncogene in the 1q31.3β1q32.1 minimal region of genomic gain in breast cancer cel
The prognostic value of the immunohistochemical expression of Sialyl Tn antigen (STn) was evaluated in 242 patients with gastric carcinoma. Formalin-fixed, paraffin-embedded specimens of gastric adenocarcinomas were stained with the monoclonal antibody C 1282, produced by immunization with ovine sub